Related Experiment Videos
Spondyloarthropathies: using presentation to make the diagnosis
Siwat Kiratiseavee1, Lawrence H Brent
1Department of Medicine, Albert Einstein Medical Center, Philadelphia, Pa, USA.
Cleveland Clinic Journal of Medicine
|April 2, 2004
Summary
Diagnosing spondyloarthropathies, chronic inflammatory joint diseases, is complex. Tumor necrosis factor inhibitors show promise as disease-modifying treatments for these challenging conditions.
Area of Science:
- Rheumatology
- Immunology
Background:
- Spondyloarthropathies are chronic inflammatory diseases affecting the spine and peripheral joints.
- Diagnosis relies on clinical history, physical examination, and radiographic assessment.
- These conditions present diagnostic challenges due to shared features.
Purpose of the Study:
- To highlight the diagnostic complexities of spondyloarthropathies.
- To discuss the emerging role of tumor necrosis factor inhibitors in managing these diseases.
Main Methods:
- Review of diagnostic criteria for spondyloarthropathies.
- Evaluation of clinical presentation and radiographic findings.
- Assessment of recent therapeutic advancements, including TNF inhibitors.
Main Results:
- Diagnostic challenges in spondyloarthropathies are significant.
- Tumor necrosis factor inhibitors represent a promising therapeutic avenue.
- These agents may offer disease-modifying effects.
Conclusions:
- Accurate diagnosis of spondyloarthropathies requires comprehensive evaluation.
- Tumor necrosis factor inhibitors are a significant advancement in treating spondyloarthropathies.
- Further research into TNF inhibitors' long-term impact is warranted.